Education
About Us
Working with TipRanks
Follow Us
Life Science Reit Plc (GB:LABS)
LSE:LABS
Total Valuation
Life Science Reit Plc has a market cap or net worth of £130.20M. The enterprise value is 281.28M.
Market Cap£130.20M
Enterprise Value281.28M
Share Statistics
Life Science Reit Plc has 350,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding350,000,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Life Science Reit Plc’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is 123.11%.
Return on Equity (ROE)-0.05
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)123.11%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.05
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Life Science Reit Plc is ―. Life Science Reit Plc’s PEG ratio is 0.27.
PE Ratio―
PS Ratio6.55
PB Ratio0.51
Price to Fair Value0.51
Price to FCF-20.92
Price to Operating Cash Flow15.33
PEG Ratio0.27
Income Statement
In the last 12 months, Life Science Reit Plc had revenue of 20.31M and earned -13.98M in profits. Earnings per share was -0.04.
Revenue20.31M
Gross Profit11.45M
Operating Income9.78M
Pretax Income-13.98M
Net Income-13.98M
EBITDA9.78M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was 8.68M and capital expenditures -10.40M, giving a free cash flow of -1.72M billion.
Operating Cash Flow8.68M
Free Cash Flow-1.72M
Free Cash Flow per Share>-0.01
Dividends & Yields
Life Science Reit Plc pays an annual dividend of 1p, resulting in a dividend yield of ―
Dividend Per Share1p
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.39
52-Week Price Change12.73%
50-Day Moving Average38.30
200-Day Moving Average40.19
Relative Strength Index (RSI)41.05
Average Volume (3m)1.26M
Important Dates
Life Science Reit Plc upcoming earnings date is Mar 31, 2026, TBA (Not Confirmed).
Last Earnings DateSep 23, 2025
Next Earnings DateMar 31, 2026
Ex-Dividend Date―
Financial Position
Life Science Reit Plc as a current ratio of 0.00, with Debt / Equity ratio of 54.24%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap0.92
Net Debt to EBITDA11.93
Interest Coverage Ratio1.06
Taxes
In the past 12 months, Life Science Reit Plc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Life Science Reit Plc EV to EBITDA ratio is 25.53, with an EV/FCF ratio of -39.26.
EV to Sales12.29
EV to EBITDA25.53
EV to Free Cash Flow-39.26
EV to Operating Cash Flow19.32
Balance Sheet
Life Science Reit Plc has £4.72M in cash and marketable securities with £126.40M in debt, giving a net cash position of -£121.68M billion.
Cash & Marketable Securities£4.72M
Total Debt£126.40M
Net Cash-£121.68M
Net Cash Per Share-£0.35
Tangible Book Value Per Share£0.75
Margins
Gross margin is 26.69%, with operating margin of 48.16%, and net profit margin of -68.83%.
Gross Margin26.69%
Operating Margin48.16%
Pretax Margin-68.83%
Net Profit Margin-68.83%
EBITDA Margin48.16%
EBIT Margin48.16%
Analyst Forecast
The average price target for Life Science Reit Plc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast4.55%
EPS Growth Forecast23.43%